The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
“It’s a beautiful drug development story. It only took eight years, but now it’s available to you,” Dr. Nooka said in the video.
The Society of Hematologic Oncology is proud to highlight some of the exceptional clinicians and researchers participating in the SOHO 2026 Young Investigator Program.
These emerging leaders are driving innovation across clinical trials, translational research, and patient care.
The roundtable panelists provide an historical overview of the DREAMM-7 and DREAMM-8 trials in multiple myeloma.
I’ve seen SOHO evolve over the dozen or so years since it was established. SOHO plays a unique role in bringing cutting-edge advances in hematologic malignancies to the broader hematology-oncology community.
SOHO Breakthroughs in Blood Cancers, a one-day virtual meeting, will be held on November 12, 2026.
SOHO 2027 is scheduled for August 25–28, 2027, in Houston, Texas at the George R. Brown Convention Center.
SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.
To access the SOHO Career Center click the following link.
